TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Austar Lifesciences Ltd. ( (HK:6118) ) has shared an announcement.
Austar Lifesciences Ltd. has announced its upcoming annual general meeting scheduled for May 23, 2025, in Shanghai, China. The meeting will address several key business items, including the adoption of the 2024 financial statements, re-election of directors, and re-appointment of the company’s auditor. Additionally, resolutions will be considered to authorize the board to manage the issuance and allotment of shares, reflecting the company’s strategic focus on maintaining governance and operational flexibility.
More about Austar Lifesciences Ltd.
Austar Lifesciences Ltd. is a company incorporated in the Cayman Islands, operating in the life sciences industry. It focuses on providing products and services related to the pharmaceutical and biotechnology sectors, aiming to support the development and manufacturing processes within these fields.
YTD Price Performance: 40.35%
Average Trading Volume: 142,576
Technical Sentiment Signal: Buy
Current Market Cap: HK$430.6M
For detailed information about 6118 stock, go to TipRanks’ Stock Analysis page.